The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
Drug combination represents one of the most accredited strategies of cancer therapy able to improve drug efficacy and possibly overcome drug resistance. Among the agents used to complement conventional chemotherapy, carbonic anhydrase IX (CAIX) inhibitors appear as one of the most suitable, as marke...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis Group
2019-01-01
|
| Saila: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Gaiak: | |
| Sarrera elektronikoa: | http://dx.doi.org/10.1080/14756366.2018.1532419 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|